Press Releases

Year

Jan 2010

LifeVantage Announces Two Human Clinical Trials Investigating the Effects of Protandim(R) on Diseases Affecting the Liver and Lungs

LifeVantage Announces Two Human Clinical Trials Investigating the Effects of Protandim(R) on Diseases Affecting the Liver and Lungs SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of Protandim® and TrueScience Anti-Aging Cream,

PDF Version

Dec 2009

LifeVantage Announces Settlement of Zrii Litigation

LifeVantage Announces Settlement of Zrii Litigation SAN DIEGO, Dec. 18 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of Protandim® and TrueScience Anti-Aging Cream, science-based solutions to oxidative stress, announced today that the Company has

PDF Version

Nov 2009

LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results

Conference call scheduled for November 18, 2009 at 1:30pm (Pacific); simultaneous webcast at www.lifevantage.com

PDF Version

Nov 2009

American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim(R)

American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim(R) SAN DIEGO, Nov. 3 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), announced that in a peer-reviewed manuscript published in the prestigious American Heart

PDF Version

Oct 2009

LifeVantage Announces Preliminary Unaudited First Quarter Revenue Company Anticipates Second Consecutive Quarter of Double Digit Percentage Increases in Net Revenue

LifeVantage Announces Preliminary Unaudited First Quarter Revenue Company Anticipates Second Consecutive Quarter of Double Digit Percentage Increases in Net Revenue LifeVantage Announces Preliminary Unaudited First Quarter Revenue Company Anticipates Second Consecutive Quarter of Double Digit

PDF Version

Oct 2009

LifeVantage to Review Fourth Quarter and Fiscal Year 2009 Financial Results and Provide Business Update

Conference call scheduled for October 15, 2009 at 1:30pm (Pacific); simultaneous webcast at www.lifevantage.com

PDF Version

Oct 2009

LifeVantage Announces Further Cost Reduction Initiatives

LifeVantage Announces Further Cost Reduction Initiatives SAN DIEGO, Oct. 7 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of Protandim® and TrueScience Anti-Aging Cream, science-based solutions for oxidative stress, announced today that it has

PDF Version

Sep 2009

LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results

LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals

PDF Version

Sep 2009

LifeVantage Granted Third Patent for Protandim® and Method for Reducing Important Inflammation Bio-Marker C-Reactive Protein

Elevated Basal Levels of C-Reactive Protein Are Considered Risk Factors for Diabetes, Hypertension, and Cardiovascular Disease

PDF Version

Aug 2009

LifeVantage Enters International Market with Pre-Launch in Mexico, One of the Top Network Marketing Countries in the World

LifeVantage Enters International Market with Pre-Launch in Mexico, One of the Top Network Marketing Countries in the World LifeVantage Corporation (OTCBB: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based

PDF Version

Pagination

First page
Previous page
…
Page 33
Page 34
Page 35
Page 36
Current page 37
Page 38
Page 39
Page 40
Page 41
…
Next page
Last page